Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4349Neoplasms 3050Prostatic Neoplasms 1902Colorectal Neoplasms 1736Lung Neoplasms 1551Carcinoma, Non-Small-Cell Lung 1268Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 950Multiple Myeloma 946Lymphoma 911Head and Neck Neoplasms 893Leukemia 851Precursor Cell Lymphoblastic Leukemia-Lymphoma 830Neoplasm Metastasis 792Colonic Neoplasms 783Carcinoma, Hepatocellular 761Ovarian Neoplasms 756Melanoma 752Stomach Neoplasms 739Rectal Neoplasms 700Brain Neoplasms 694Lymphoma, Non-Hodgkin 658Leukemia, Lymphocytic, Chronic, B-Cell 617Uterine Cervical Neoplasms 605Lymphoma, Follicular 559Glioblastoma 538Recurrence 537Hodgkin Disease 530Esophageal Neoplasms 527Myelodysplastic Syndromes 507

Interventions

Saline Solution 1Lidocaine 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × OTHER × Scleroderma, Localized × Clear all
NCT03630198 2021-03-11

Pain Outcomes Following Intralesional Corticosteroid Injections

Vanderbilt University Medical Center

Phase 4 Completed
31 enrolled 6 charts

Acne Vulgaris, Alopecia Areata, Dermoid Cyst, Keloid, Keratoacanthoma, Lichen Planus, Neurodermatitis, Scleroderma, Localized, Granuloma Annulare, Cicatrix, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡